The 8th Annual Pharma Regulatory Summit 2025 is dedicated to pharma Regulatory.
Topics
Political landscape: how could medical policy be affected?
Assure access to medications: How will regulatory weaknesses in pharmaceuticals be addressed?
Present regulatory system for the growth and effective production of medicinal products in scientific and technological ways
Addressing political mechanisms and advantages intended to regulate the business.
Regulatory and consumer opportunities for patients to approve and retain critical drugs
Discussing how to ensure operational performance in compliance with the aim of better regulation.
Regulatory structure for complex off-patent drugs, from the viewpoint of global product growth
Addressing existing problems in the growth of more complex off-patent medicinal products
Discussing the efficiency of the devices and regulatory initiatives
Regulatory challenges for medical devices
Addressing the Indian System of Medicine`s acceptance of the new medical science by health personnel.
Priorities of new Indian Commission`s policies relevant to pharmaceuticals
Addressing patient`s health and health care delivery data that are regularly obtained from a number of sources
Real word evidence: How it could be used to facilitate regulatory decision-making
Addressing the problem as well as other supply chain issues
Possible legislative options to help minimise the risk of shortages and to reduce them
Guidelines for national regulatory authorities for medical products
Initiatives of regulatory convergence – How the regulators and stakeholders of medical products may benefit from the guidance and convergence activities in India.
